arrow
C

Christopher R. Cogle

university of florida
H指数:42
被引数:8,435

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia

急性髓系白血病的表观基因组学诊断与预后

2025-07-290
OAAI
Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial

白血病相关突变(LAMs)在诱导治疗后清除与中危急性髓系白血病的不良预后相关:一项多中心、前瞻性II期试验的 interim 结果

BLOOD
IF23.1
2024-11-050
PRE
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
2023-07-015
OAAI
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial

Entospletinib联合地西他滨治疗TP53突变或复杂核型的急性髓系白血病: Beat AML Master试验的2期子研究

CANCER
IF5.1
2023-04-207
PRE
Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA

CD3xCD123双特异性抗体APVO436在对HMA或Venetoclax加HMA耐药的复发/难治性AML和MDS中的药效学和单药活性的事后分析

2022-01-132
OAAI
Identification of Unique mRNA and miRNA Expression Patterns in Bone Marrow Hematopoietic Stem and Progenitor Cells After Trauma in Older Adults
2020-06-2410
OAAI
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
2019-06-1711
OA